[Myoadenylate deaminase deficiency among patients with myasthenia gravis--preliminary results of exercise].
Myasthenia Gravis (MG) is a primary disorder of neuromuscular transmission, and patients suffering from this disease manifest specific, progressive weakness of several groups of skeletal muscles. Myoadenylate deaminase deficiency (MADD) is an inborn disease of skeletal muscles, the clinical symptoms of which may mimic symptoms observed in MG. Preliminary results of studies presented in this paper suggest that simultaneous occurrence of MG and MADD may modify energetic metabolism of skeletal muscle.
Bilińska
Małgorzata
M
Katedra i Klinika Neurologii Dorosłych Akademii Medycznej w Gdańsku.
Chodorowski
Zygmunt
Z
Nyka
Walenty
W
Nyka
Wiesława
W
Rybakowska
Iwona
I
Smoleński
Ryszard
R
Kaletha
Krystian
K
D000659:AMP Deaminase / Q000172:deficiency*; D000293:Adolescent; D000328:Adult; D015444:Exercise; D005080:Exercise Test; D005260:Female; D006801:Humans; D008297:Male; D018482:Muscle, Skeletal / Q000201:enzymology* / Q000473:pathology; D009157:Myasthenia Gravis / Q000201:enzymology* / Q000235:genetics / Q000503:physiopathology; D009468:Neuromuscular Diseases / Q000201:enzymology
D000659:AMP Deaminase